Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?

By Omura G.A.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 498-498

Elsevier

Access to resources Recommend Favorite

Procollagen-Derived Biomarkers in Malignant Ascites of Ovarian Cancer Independent Prognosticators for Progression-Free Interval and Survival

By Cracchiolo B.M.   Hanauske-Abel H.M.   Schwartz P.E.   Chambers J.T.   Holland B.   Chambers S.K.  

Gynecologic Oncology, Vol. 87, Iss. 1, 2002-10 ,pp. : 24-33

Academic Press

Access to resources Recommend Favorite

Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer

By Tas Faruk   Karabulut Senem   Serilmez Murat   Ciftci Rumeysa   Duranyildiz Derya  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 631-637

Springer Publishing Company

Access to resources Recommend Favorite

Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery

By Stoeckle Eberhard   Bourdarias Lionnel   Guyon Frédéric   Croce Sabrina   Brouste Véronique   Thomas Laurence   Floquet Anne  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 629-636

Springer Publishing Company

Access to resources Recommend Favorite

Elevated nm23 Protein Expression Is Correlated with Diminished Progression-Free Survival in Patients with Epithelial Ovarian Carcinoma

By Srivatsa P.J.   Cliby W.A.   Keeney G.L.   Dodson M.K.   Suman V.J.   Roche P.C.   Podratz K.C.  

Gynecologic Oncology, Vol. 60, Iss. 3, 1996-03 ,pp. : 363-372

Academic Press

Access to resources Recommend Favorite